Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank50
3Y CAGR-4.8%
5Y CAGR+98.2%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-4.8%/yr
Annual compound
5Y CAGR
+98.2%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
30.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 28.95% | -11.3% |
| 2024 | 32.66% | -14.2% |
| 2023 | 38.06% | +13.5% |
| 2022 | 33.54% | +27.3% |
| 2021 | 26.34% | +2681.3% |
| 2020 | 0.95% | +100.0% |
| 2019 | -2380.22% | - |